SCHEMBL4026201

SCHEMBL4026201

Oc1[nH]nnc1-c1cccnc1-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 1/20 0.42
▸ PTGS2 P35354 1/20 0.42
▸ NTRK1 P04629 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ HTT P42858 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ FEN1 P39748 1/20 0.35
▸ PTPRC P08575 2/20 0.35
▸ CTSL P07711 1/20 0.35
▸ CTSS P25774 1/20 0.35
▸ PTPN13 Q12923 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ MGAM O43451 1/20 0.35
▸ KMT2A Q03164 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ TDP2 O95551 1/20 0.34
▸ NSD2 O96028 1/20 0.34
▸ ABL1 P00519 1/20 0.34
▸ PLCG1 P19174 1/20 0.34
▸ CES1 P23141 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4021374 0.83 KDM4E (0.57) ALDH1A1KMT2AMEN1GAAKDM4E
SCHEMBL170101 0.81 ALOX15 (0.43) ALDH1A1HTTHSD17B10L3MBTL1KMT2A
Ammonia Solution, Strong SCHEMBL28924316 0.79 ALOX15 (0.41) ALDH1A1HTTHSD17B10KMT2AMEN1
SCHEMBL21692150 0.75 PTGS1 (0.58) PTGS1PTGS2NTRK1ALDH1A1HTT
Piperazine SCHEMBL28290172 0.73 HTR7 (0.42) ALDH1A1HSD17B10KMT2AMEN1GAA
SCHEMBL37278 0.73 PTGS2 (0.66) PTGS1PTGS2NTRK1ALDH1A1HTT
SCHEMBL12854120 0.73 PTPRC (0.57) PTGS1PTGS2NTRK1ALDH1A1HTT
SCHEMBL14663825 0.73 PTGS1 (0.43) PTGS1PTGS2NTRK1ALDH1A1HTT
Ammonia Solution, Strong SCHEMBL20599554 0.72 PTGS2 (0.64) PTGS1PTGS2NTRK1ALDH1A1HTT
SCHEMBL29227428 0.72 PTGS2 (0.64) PTGS1PTGS2NTRK1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613617-A4 DI-ARYL SUBSTITUTED TRIAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO INC (US) 2009-02-18 — — EP disclosed
EP-1613617-A2 DI-ARYL SUBSTITUTED TRIAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 Merck & Co., Inc. (US) 2006-01-11 — — EP disclosed
EP-1458708-A4 HETEROARYL SUBSTITUTED TRIAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO INC (US) 2005-11-16 — — EP disclosed
WO-2004089306-A2 DI-ARYL SUBSTITUTED TRIAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO., INC. (US) 2004-10-21 — — WO disclosed
EP-1458708-A2 HETEROARYL SUBSTITUTED TRIAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 Merck & Co., Inc. (US) 2004-09-22 — — EP disclosed
WO-2003051315-A2 HETEROARYL SUBSTITUTED TRIAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO., INC. (US) 2003-06-26 — — WO disclosed
Send feedback